Long Term Safety of Amifampridine Phosphate in Spinal Muscular Atrophy 3
Clinical trial NCT03819660 · TERMINATED
Trial details
- NCT number
- NCT03819660
- Sponsor
- Catalyst Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-03-07
- Primary completion
- 2021-09-13
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.